Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are anticipating strong results driven by the strong demand of Lilly's blockbuster treatments, particularly recent launches. However, there are also concerns about potential headwinds from re… Read More